They identify bioactive compounds from sage and rosemary that could fight breast cancer

They identify bioactive compounds from sage and rosemary that could fight breast cancer

A multidisciplinary team of Institute of Chemical Technology (ITQ) -mixed center of the Higher Council of Scientific Research (CSIC), of the Polytechnic University of Valencia (UPV)-, in the east of Spain, and the Louisiana State University (LSU) from the United States, identified new bioactive compounds from sage and rosemary that could help in the fight against breast cancer.

Researchers for the first time demonstrated in breast cancer models, antitumor properties of tanshinone IIA and carnosol, compounds from sage and rosemary, according to a statement from the CSIC.

These findings suggest the potential of these bioactive compounds for the development of new therapeutic agents against breast cancer, “one of the most common and deadly diseases in women worldwide and, despite advances in diagnosis and treatment, remains difficult to treat and with a high mortality rate,” the statement says.

What’s more, according to the World Health Organization (WHO), this disease represents 16% of all cancers in female patients. For this reason, the search for new compounds and therapies is essential to improve the survival and quality of life of patients, the note adds.

They demonstrated anticancer activities

The work, whose results were published in the magazine “Cancers”, focuses on tanshinone IIA, a substance from the Salvia miltiorrhiza plant, and carnosol, which is found in rosemary (Salvia Rosmarinus).

“Both compounds have shown anti-cancer activities in laboratory tests in real organisms. However, there are hardly any studies on the pharmacological properties of the structural analogues of these molecules,” says Miguel Angel Gonzalez Cardenete, CSIC researcher and lead author of the work.

In their study, ITQ researchers synthesized analogues of tanshinone and carnosol, through a sustainable process using materials from pine resin.

While Fatima Rivas’s (LSU) team evaluated its antitumor activity in breast cancer cell lines, including triple-negative breast cancer models (without estrogen and progesterone hormone receptors or human epidermal growth factor receptor 2, HER2). ).

“This subtype of breast cancer is very aggressive, develops rapidly and has low survival rates. and lacking the three most common types of receptors, they do not respond to anti-hormonal or anti-HER2 therapy, which is why there are few effective and very expensive chemotherapy treatments,” says Fatima Rivas, professor at LSU.

It is worth remembering that the month of October commemorates the fight against breast cancer “in order to raise awareness and generate awareness so that women can access timely diagnosis and treatment.”emphasizing early detection strategies,” states the website of the Network of Family Health Centers of the Faculty of Medicine of the Catholic University.

They inhibit the proliferation of breast cancer cells

The results showed that several of the analogues inhibited the proliferation of breast cancer cells and increased programmed cell death at very small concentrations and with moderate selectivity indices with respect to non-tumor cells.

These findings suggest the potential of tanshinone and carnosol analogues for the development of new therapeutic agents against breast cancer.. “However, further research is needed to fully understand the underlying mechanisms of action and validate the efficacy of these compounds in animal models and clinical trials before their possible application in the treatment of breast cancer,” concludes Miguel Angel Gonzalez Cardenete, researcher. from the CSIC at the ITQ.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!